despit
signific
progress
recent
effort
toward
develop
effect
vaccin
toxoplasmosi
search
new
protect
vaccin
strategi
still
remain
challeng
elus
goal
becom
appropri
way
prevent
diseas
variou
experiment
approach
past
year
show
develop
potenti
vaccin
diseas
achiev
combin
multiepitop
express
differ
stage
parasit
life
cycl
becom
optim
strategi
acquir
potent
safe
effect
vaccin
epitopebas
vaccin
gain
attent
altern
vaccin
candid
due
abil
induc
protect
immun
respons
minireview
highlight
current
statu
prospect
toxoplasma
gondii
vaccin
develop
along
applic
epitopebas
vaccin
futur
parasit
immun
novel
develop
evalu
strategi
articl
histori
toxoplasmosi
preval
diseas
caus
toxoplasma
gondii
gondii
zoonot
parasit
infect
human
domest
wild
mammal
signific
lifethreaten
diseas
medic
veterinari
econom
import
worldwid
immunocompet
individu
infect
toxoplasmosi
usual
asymptomat
might
mild
symptom
diseas
immunocompromis
patient
quit
sever
even
fatal
despit
sever
avail
antiparasit
chemic
drug
use
prevent
cure
infect
limit
control
spread
gondii
parasit
infect
host
drug
still
limit
efficaci
absolut
safe
could
caus
sever
side
effect
thu
acquir
safe
effect
vaccin
control
vital
impact
toxoplasmosi
human
anim
urgent
need
intens
effort
signific
advanc
toward
acquir
effect
vaccin
way
control
infect
limit
incid
diseas
howev
vaccin
thu
far
avail
use
human
current
live
attenu
tachyzoit
strain
commerci
name
toxovax
approv
vaccin
veterinari
use
vaccin
unfortun
shown
limit
efficaci
consequ
numer
studi
toxoplasmosi
vaccin
conduct
differ
form
parasit
parasit
antigen
test
includ
inactiv
life
attenu
vaccin
crude
recombin
antigen
subunit
multiantigen
vaccin
dna
vaccin
interestingli
result
indic
acquir
effect
vaccin
toxoplasmosi
achiev
lack
avail
vaccin
highlight
need
explor
altern
reagent
use
immun
purpos
discuss
conduct
address
challeng
along
difficulti
acquir
potenti
vaccin
construct
mani
suggest
propos
put
forward
order
identifi
possibl
direct
futur
research
studi
develop
potenti
vaccin
gondii
respons
scenario
scientif
suggest
base
pay
special
focu
multiepitop
antigen
contain
variou
immunoreact
epitop
differ
gondii
antigen
potenti
use
epitopebas
antigen
explor
develop
new
approach
expect
meet
demand
achiev
effect
vaccin
character
identif
immunogen
epitop
organ
antigen
could
help
develop
sensit
diagnost
assay
potenti
vaccin
well
effect
therapeut
agent
applic
epitopebas
vaccin
immun
attempt
variou
infect
shown
encourag
result
prove
stimul
protect
cellular
humor
immun
accordingli
epitopebas
vaccin
suggest
new
potenti
candid
acquir
novel
effect
gondii
vaccin
date
larg
number
immun
attempt
highlight
futur
gondii
vaccin
approach
appli
antigen
potenti
stimul
protect
immun
parasit
express
parasit
life
stage
therefor
epitopebas
vaccin
featur
excel
immunogen
valuabl
acquir
new
immun
strategi
review
summar
approach
develop
vaccin
toxoplasmosi
emphasi
epitopebas
vaccin
describ
design
construct
strategi
vaccin
advantag
disadvantag
current
applic
type
vaccin
toxoplasmosi
vaccin
strategi
develop
protect
vaccin
gondii
parasit
reduc
high
incid
diseas
prevent
clinic
outcom
human
anim
therefor
effect
immun
expect
reduc
shed
oocyst
prevent
cyst
format
vaccin
would
significantli
reduc
parasit
transmiss
intermedi
host
definit
improv
diseas
control
econom
vaccin
could
also
reduc
loss
livestock
industri
thu
achiev
effect
vaccin
toxoplasmosi
high
prioriti
extrem
import
given
high
incid
diseas
worldwid
well
seriou
veterinari
clinic
outcom
parasit
includ
chorioretin
abort
mental
defect
death
last
year
differ
immun
strategi
achiev
effect
gondii
vaccin
investig
consequ
protect
level
evalu
differ
type
immunogen
includ
follow
lifeattenu
parasit
kill
vaccin
nativ
parasit
antigen
recombin
antigen
dna
vaccin
immunogen
test
new
immun
strategi
moreov
inocul
live
parasit
significantli
induc
effect
immun
protect
toxoplasmosi
reinfect
despit
signific
effort
develop
gondii
vaccin
live
attenu
tachyzoit
strain
commerci
name
toxovax
approv
licens
minim
abort
rate
sheep
unfortun
vaccin
use
human
immun
risk
revert
virul
form
likewis
vaccin
may
pathogen
immunocompromis
patient
toxovax
short
shelf
life
entail
high
cost
addit
immun
strain
wide
use
gondii
immun
studi
provid
signific
resist
cyst
format
partial
protect
congenit
toxoplasmosi
approach
increas
surviv
rate
acut
toxoplasmosi
mous
inocul
temperaturesensit
mutant
strain
induc
protect
immun
lethal
infect
parasit
challeng
contrast
inject
mice
kill
tachyzoit
lysat
provid
protect
neither
alon
adjuv
despit
numer
vaccin
strategi
studi
well
vast
knowledg
molecular
genet
immunolog
patholog
relat
gondii
pathogen
safe
protect
vaccin
exist
human
anim
thu
far
inform
obtain
larg
number
immun
attempt
indic
futur
gondii
vaccin
approach
use
antigen
potenti
stimul
cellmedi
immun
parasit
express
parasit
life
stage
compat
appropri
vaccin
rout
key
step
control
gondii
infect
prevent
oocyst
format
definit
host
cat
felin
given
cat
sourc
oocyst
probabl
transmiss
infect
intermedi
host
occur
contamin
fece
develop
protect
vaccin
use
speci
must
abl
limit
shed
oocyst
prevent
environment
contamin
oocyst
studi
thu
far
focus
cat
vaccin
use
live
mutant
bradyzoit
name
first
trial
kitten
vaccin
oral
inocul
kitten
gener
protect
immun
oocyst
shed
success
prevent
cat
challeng
gondii
parasit
unfortun
mani
disadvantag
includ
need
use
live
bradyzoit
high
cost
similarli
effect
coirradi
tachyzoit
stimul
protect
immun
beverley
strain
gondii
investig
vaccin
induc
partial
resist
infect
challeng
howev
vaccin
show
disadvantag
need
refriger
high
cost
oocyst
shed
reduc
dna
vaccin
encod
rhoptri
protein
rop
use
even
though
dna
vaccin
current
show
potenti
immun
tool
pig
live
gondii
vaccin
exhibit
mild
protect
parasit
still
show
risk
revert
virul
type
caus
diseas
thu
speci
develop
kill
vaccin
necessari
recent
intraderm
immun
pig
dna
vaccin
express
toxoplasma
antigen
elicit
high
humor
cellular
immun
studi
prove
dna
vaccin
could
effect
induc
strong
immun
protect
addit
potenti
tachyzoit
strain
reduc
number
cyst
pork
thu
improv
food
safeti
highlight
among
variou
approach
acquir
effect
gondii
vaccin
recombin
dna
technolog
altern
strategi
great
potenti
immunolog
effect
sever
toxoplasma
recombin
antigen
wide
evalu
last
year
includ
surfac
antigen
sag
micronem
protein
densegranul
protein
gra
rop
limit
antigen
capabl
induc
strong
protect
immun
unluckili
recombin
antigen
tend
lack
immunogen
especi
vaccin
trail
intracellular
pathogen
therefor
use
appropri
adjuv
requir
enhanc
potenc
addit
product
recombin
protein
within
anoth
express
system
organ
could
caus
allerg
reaction
establish
dna
vaccin
strategi
open
new
perspect
futur
vaccin
develop
recent
variou
dna
vaccin
gondii
develop
evalu
shown
promis
abil
vaccin
induc
high
humor
cellmedi
immun
make
promis
vaccin
strategi
intracellular
pathogen
includ
toxoplasma
dna
vaccin
exhibit
sever
advantag
easi
produc
easi
administ
stabl
immunogen
possess
potenti
longlast
immun
addit
dna
vaccin
show
high
flexibl
sever
type
gene
encod
one
dna
vaccin
moreov
dna
vaccin
littl
risk
revert
virul
form
caus
secondari
infect
antigen
variat
genet
polymorph
repres
major
obstacl
attempt
acquir
success
vaccin
particular
pathogen
therefor
understand
variat
polymorph
popul
crucial
proper
vaccin
design
evalu
data
might
also
provid
invalu
insight
parasitehost
interact
improv
knowledg
bioinformat
tool
along
advanc
recombin
dna
technolog
allow
new
strategi
toward
design
product
novel
epitopebas
vaccin
epitop
antigen
determin
minim
immunogen
part
particular
antigen
capabl
induc
specif
immun
respons
accordingli
variou
immunogen
epitop
identifi
differ
infecti
pathogen
cancer
significantli
improv
develop
potenti
epitopebas
vaccin
improv
understand
immun
cell
recogn
interact
pathogen
antigen
molecular
cellular
level
signific
contribut
develop
acquir
ration
design
epitop
vaccin
concept
epitop
vaccin
mainli
reli
predict
immunodomin
b
cell
epitop
elicit
specif
protect
immun
respons
antigen
variat
infecti
agent
imped
develop
effect
vaccin
therefor
use
immunogen
peptid
trial
acquir
epitopebas
vaccin
recent
drawn
attent
critic
requir
includ
proper
identif
b
cell
epitop
well
select
novel
power
approach
deliv
epitop
immun
multiepitop
vaccin
express
tcell
orand
bcell
epitop
differ
pathogen
show
signific
increas
cellular
humor
immun
respons
well
prolong
surviv
time
numer
studi
identifi
potenti
epitopebas
antigen
could
effect
induc
high
protect
immun
divers
pathogen
approach
use
develop
evalu
vaccin
variou
infecti
agent
influenza
viru
human
immunodefici
viru
epsteinbarr
viru
hepat
b
viru
potenti
advantag
use
vaccin
strategi
follow
decreas
biohazard
risk
associ
type
immun
abil
ration
engin
optim
epitop
structur
increas
potenc
elicit
strong
immun
provid
opportun
focu
gener
specif
immun
respons
known
conserv
immunodomin
epitop
addit
lack
infecti
potenti
epitopebas
vaccin
also
show
chemic
stabil
therefor
kind
vaccin
develop
test
variou
infecti
agent
includ
parasit
bacteri
fungal
viral
infect
well
cancer
clinic
trial
variou
cancer
peptid
vaccin
enter
phase
ii
satisfactori
promis
clinic
outcom
howev
effort
need
elimin
associ
obstacl
includ
necess
better
adjuv
well
low
orand
lack
result
immunogen
antigen
process
present
nonetheless
studi
show
signific
progress
defi
limit
develop
potenti
epitop
vaccin
requir
proper
predict
valid
highli
immunogen
epitop
capabl
induc
protect
immun
respons
constitut
basi
vaccin
develop
shown
figur
fact
signific
barrier
design
kind
vaccin
epitop
identif
therefor
predict
identifi
b
cell
epitop
significantli
further
understand
immun
respons
pathogen
gener
increas
chanc
develop
potenti
vaccin
mechan
action
epitopebas
vaccin
gener
specif
immun
respons
illustr
figur
bioinformat
tool
remain
vital
option
analyz
immunogen
epitop
high
antigen
immunogen
even
though
inher
complex
microbi
antigen
recognit
complic
process
epitop
predict
yet
signific
effort
put
toward
acquir
novel
strategi
effici
tool
epitop
analysi
consequ
differ
algorithm
develop
test
predict
screen
possibl
epitop
result
indic
promis
strategi
vaccin
develop
applic
bioinformat
approach
analysi
conserv
sequenc
predict
potenti
epitop
wide
use
variou
pathogen
repres
power
altern
strategi
epitop
discoveri
significantli
reduc
cost
time
well
effort
involv
experiment
approach
epitop
screen
howev
variat
among
epitop
region
might
affect
predict
process
thu
acquir
function
protect
epitop
select
immunogen
epitop
crucial
design
particular
epitopebas
vaccin
therefor
differ
pathogen
genotyp
subtyp
taken
account
sinc
applic
bioinformat
tool
product
epitopebas
antigen
becom
potenti
strategi
acquir
novel
power
vaccin
infecti
agent
consider
effort
made
toward
develop
promis
epitopebas
vaccin
toxoplasmosi
tabl
research
assum
construct
singleor
multiepitopebas
antigen
express
potenti
b
orand
cell
epitop
tachyzoit
bradyzoit
specif
antigen
would
greatli
improv
gondii
immun
strategi
accordingli
sever
studi
conduct
result
identif
variou
promis
epitop
capabl
induc
protect
immun
respons
would
possibl
contribut
attempt
develop
protect
vaccin
gondii
evidenc
signific
immun
protect
gener
mice
model
recent
synthet
vaccin
express
nine
epitop
predict
gondii
test
balbc
mice
immun
multiepitop
vaccin
significantli
gener
mix
antibodi
respons
high
product
cytokin
similarli
signific
increas
cellular
humor
immun
gener
mice
immun
multiepitop
vaccin
contain
two
cell
epitop
one
b
cell
epitop
addit
vaccin
mice
obtain
longterm
surviv
rate
compar
unvaccin
control
contrast
epitop
vaccin
compos
singl
b
cell
epitop
use
previous
confirm
elicit
strong
immun
respons
instanc
synthet
b
cell
epitop
identifi
antigen
abl
stimul
cellular
humor
immun
increas
surviv
rate
immun
anim
similarli
mice
immun
epitop
vaccin
identifi
form
protein
induc
signific
b
cell
immun
respons
also
indic
effect
protect
follow
parasit
challeng
pru
strain
gondii
cyst
howev
effect
system
mucos
immun
enhanc
singl
mix
peptid
strong
lymphoprolif
respons
associ
signific
product
high
level
specif
antibodi
respons
addit
partial
immun
protect
acut
chronic
toxoplasmosi
also
gener
furthermor
combin
dna
peptid
vaccin
significantli
reduc
format
brain
cyst
among
immun
mice
emphas
involv
singl
mixtur
epitop
shown
remark
induc
effect
humor
cellular
immun
respons
toxoplasmosi
could
power
effici
strategi
consid
product
possibl
protect
vaccin
candid
toxoplasmosi
develop
potenti
vaccin
gondii
significantli
progress
last
year
numer
experiment
studi
prevent
immun
explor
variou
form
gondii
antigen
includ
liveattenu
vaccin
subunit
vaccin
recombin
vaccin
dna
vaccin
accordingli
signific
stride
conduct
antigen
isol
character
gene
clone
immunolog
techniqu
addit
prevent
strategi
new
option
produc
effect
vaccin
current
need
appropri
way
prevent
diseas
previou
studi
develop
effect
vaccin
gondii
reveal
vaccin
express
singl
antigen
singl
stage
induc
partial
immun
protect
parasit
thu
vaccin
express
multipl
stage
parasit
life
cycl
must
synthes
adopt
bioinformat
identifi
antigen
epitop
theoret
arrang
multipl
epitop
singl
antigen
could
aid
achiev
potenti
gondii
vaccin
use
epitopebas
antigen
highli
promis
develop
potenti
vaccin
candid
would
gener
last
protect
immun
reaction
gondii
furthermor
use
epitopebas
antigen
could
import
approach
investig
improv
diseas
vaccin
futur
futur
studi
also
consid
explor
tabl
list
predict
epitop
evalu
potenti
epitopebas
vaccin
lgpvklsaegpt
taakthtvrgfkv
syfaadrlvp
klfettdmi
vrqeaiaralaraaa
anophel
mosquito
salivari
protein
gniegqwalknhslvslseqvlvscdnidd
cpa
cystein
peptidas
ysnigvck
qtliaihtlairyan
paracoccidioid
brasiliensi
antigen
rppifirrl
ssvrdrlarl
residu
gene
footandmouth
diseas
viru
takdgmeyynkmgelykq
rcllgfkevggkcvpasi
plasmodium
knowlesi
merozoit
surfac
tcpdkksta
ksfkdilpk
stfwpcllr
avvsllrllk
ssayvfsvk
amltafflr
appropri
adjuv
use
along
epitopebas
vaccin
strategi
establish
optim
immun
protocol
along
evalu
criteria
